# OnCo record natera-mced (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/natera-mced/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "natera-mced" ;
  schema:name "Natera multi-cancer early detection assay"@en ;
  schema:description "Natera's blood test in development for several cancers, given FDA Breakthrough Device designation in October 2026 on data from 12 cancer types; no performance figures have been published."@en ;
  schema:url <https://onco.cc/drugs/natera-mced/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://investor.natera.com/news/news-details/2026/FDA-Grants-Breakthrough-Device-Designation-for-Nateras-Multi-Cancer-Early-Detection-Assay/default.aspx> ;
  onco:status "emerging" ;
  onco:tag "test", "mced", "evidence:insufficient" ;
  onco:modality "Multi-cancer early detection blood test in development (cell-free DNA)" ;
  schema:alternateName "Natera MCED" ;
  onco:related <https://onco.cc/drugs/shield-mcd/>, <https://onco.cc/drugs/galleri/> ;
  onco:technologies <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:companies <https://onco.cc/companies/natera/> .